Empyrean Technology (301269) Q3 2026 earnings summary

Executive summary

• Q3 revenue was ¥393.7m, up 29.82% YoY; parent-attributable net income was ¥72.0m, while adjusted net income was ¥34.2m. YTD revenue grew 19.30%, but adjusted net income remained negative.

• Q3 financial statements were unaudited; YTD operating cash flow was negative ¥111.8m, compared with positive ¥184.6m in the prior-year period.

Financial highlights

• YTD revenue rose to ¥960.1m from ¥804.8m; parent-attributable net income increased to ¥26.9m from ¥9.1m.

• YTD adjusted net income was a loss of ¥31.0m, down 39.71% YoY; Q3 adjusted net income was ¥34.2m, up 1,067.08%.

• YTD operating costs increased to ¥1,044.6m from ¥881.2m; R&D expense was ¥629.9m versus ¥556.9m.

• Other income reached ¥128.4m YTD, up from ¥88.3m, mainly due to increased government-grant income.

Key financial ratios and metrics

• Basic and diluted EPS were ¥0.1313 for Q3, up 1,093.64% YoY, and ¥0.0491 YTD, up 195.78%.

• Weighted-average ROE was 1.37% for Q3 and 0.51% YTD, compared with 1.25% and 0.33%, respectively, in the prior-year periods.

• Period-end total assets were ¥6,253.9m, down 1.17% from year-end; equity attributable to parent shareholders was ¥5,384.7m, up 2.53%.